- LabMaus
Gdansk has come to an end and Federico Camporesi is your new champion with a dominant rain team! Incredible matches all throughout top 8, make sure to check it out
- Home - Maus Lab
We are scientists with a passion for translating our laboratory findings into new therapies for cancer patients Our goal is to understand what makes gene-modified T cells work well in patients, without significant toxicity, and to invent new forms of gene-modified immune cells to treat cancer
- Maus Lab - Massachusetts General Hospital
The goal of the Maus lab is to design and evaluate next generation genetically-modified (CAR) T cells as immunotherapy in patients with cancer Team: Max Jan, MD, Robert Manguso, PhD, Marcela Maus, MD, PhD and Debattama Sen, PhD Learn more about the team's project and the Krantz Awards
- Home | Aging And Cancer Lab
We create technologies and treatments to detect and reverse age-related biological processes that promote cancer Our vision is a future in which tissues undergoing accelerated aging can be non-invasively detected, and rejuvenated to eradicate cancer before it arises
- Maus Lab Team - Maus Lab
Now, Dr Maus is a Professor of Hematology and Oncology at Massachusetts General Hospital and Harvard Medical School, where she runs a laboratory focused on developing and improving CAR T cell therapy for cancer patients while also periodically attending for the bone marrow transplant service
- LabMaus
Search: Your #1 VGC tournament analysis resource
- LabMaus website is now live! | Patreon
LabMaus website is now live! We are officially upgrading from the labmaus discord bot, and moving onto a website! https: thelabmaus com is now live, with the hope to make tournament data far more accessible than needing a discord page and a good understanding of the commands
- Publications | Aging And Cancer Lab
Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells, López-Polo V, Maus M, Zacharioudakis E, Lafarga M, Attolini CS, Marques FDM, Kovatcheva M, Gavathiotis E, Serrano M - Nature Communications 2024
|